Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research
This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pages
and full FOA presentations are available on the FOA webinars page. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.
FOAs Sponsored or Co-Sponsored by HDRP
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date | Program Contact |
|---|---|---|---|
| Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) | RFA-CA-19-035 (R01 Clinical Trial Required) |
June 29, 2019 | Michelle Mollica 240-276-7621 michelle.mollica@nih.gov |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-18-008 (R01 Clinical Trial Optional) PAR-16-337 (R03) PAR-18-019 (R21 Clinical Trial Optional) |
July 6, 2019 (R01) July 17, 2019 (R03 and R21) |
Sarah Kobrin 240-276-6931 kobrins@mail.nih.gov |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies | PAR-16-368 (R33) |
September 8, 2019 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Research Infrastructure Development for Interdisciplinary Aging Studies | PAR-16-367 (R21) |
September 8, 2019 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Methodology and Measurement in the Behavioral and Social Sciences | PAR-18-352 (R01 Clinical Trial Optional) PAR-18-378 (R21 Clinical Trial Optional) |
September 8, 2019 | Sandra Mitchell 240-276-6929 mitchellsa@cc.nih.gov |
| Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors | RFA-CA-19-033 (U01 Clinical Trial Required) |
January 4, 2020 | Sandra Mitchell 240-276-6929 mitchlls@mail.nih.gov |
| Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults | PA-18-005 (R01 Clinical Trial Optional) PA-18-015 (R21 Clinical Trial Optional) |
January 8, 2020 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers | PA-18-149 (R01 Clinical Trial Optional) PA-18-167 (R21 Clinical Trial Optional) |
January 8, 2020 | Michelle Mollica 240-276-7621 michelle.mollica@nih.gov |
| Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery | PA-18-004 (R01 Clinical Trial Optional) PA-18-014 (R21 Clinical Trial Optional) |
January 8, 2020 | Wendy Nelson 240-276-6971 nelsonw@mail.nih.gov |
| Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests | PA-17-495 (R01 Clinical Trial Optional) |
January 8, 2021 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer | PA-18-492 (R21 Clinical Trial Optional) PA-18-493 (R01 Clinical Trial Optional)
|
May 8, 2021 | Gurvaneet Randhawa 240-276-6940 gurvaneet.randhawa@nih.gov |
| Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) | PA-18-932 |
January 8, 2022 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses | PAR-19-136 (R01 Clinical Trial Optional) PAR-19-153 (R21 Clinical Trial Optional) |
January 8, 2022 | Ashley Wilder Smith 240-276-7621 smithas@mail.nih.gov |
Other FOAs Relevant to HDRP
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date | Program Contact |
|---|---|---|---|
| Dissemination and Implementation Research in Health | PAR-19-274 (R01) PAR-19-275 (R21) PAR-19-276 (R03) |
May 8, 2022 | Gila Neta 240-276-6785 netagil@mail.nih.gov Wynne E. Norton, Ph.D. National Cancer Institute (NCI) 240-276-6875 Wynne.Norton@nih.gov David Chambers 240-276-5090 dchamber@mail.nih.gov |
| Cancer-Related Behavioral Research through Integrating Existing Data | PAR-16-256 (R01) PAR-16-255 (R21)
|
June 15, 2019 | Rick Moser 240-276-6915 moserr@mail.nih.gov |
| Addressing Health Disparities through Effective Interventions Among Immigrant Populations | PA-18-284 (R01 Clinical Trial Optional) PA-18-285 (R21 Clinical Trial Optional)
|
January 8, 2020 | Shobha Srinivasan 240-276-6938 ss688k@nih.gov |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Research to Improve Native American Health (R21 Clinical Trials Optional) |
PAR-17-496 (R01) PAR-17-464 (R21)
|
May 15, 2020 | Shobha Srinivasan 240-276-6938 ss688k@nih.gov |
NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date |
|---|---|---|
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) | PA-18-484 (R01)
|
January 8, 2021 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | PAR-18-559
|
January 8, 2021 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | PAR-18-869
|
March 9, 2021 |
Visit https://grants.nih.gov/grants/guide/parent_announcements.htm for a full list of all NIH parent announcements.